Chen Jibing
Overview
Explore the profile of Chen Jibing including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chunhui G, Yanqiu Y, Jibing C, Ning L, Fujun L
Metab Brain Dis
. 2025 Jan;
40(1):84.
PMID: 39754674
Alzheimer's disease (AD) is a neurodegenerative disease that primarily affects the elderly population and is the leading cause of dementia. Meanwhile, the vascular hypothesis suggests that vascular damage occurs in...
2.
Chang C, Weiping L, Jibing C
Cell Mol Neurobiol
. 2024 Dec;
45(1):3.
PMID: 39652146
Central nervous system diseases include central nervous system injury diseases, neurodegenerative diseases, and other conditions. MicroRNAs (miRNAs) are important regulators of gene expression, with therapeutic potential in modulating genes, pathways,...
3.
Mei L, Yuwei Y, Weiping L, Zhiran X, Bingzheng F, Jibing C, et al.
Cell Transplant
. 2024 Jun;
33:9636897241259433.
PMID: 38877672
Islet transplantation may be the most efficient therapeutic technique for patients with type 1 diabetes mellitus (T1DM). However, the clinical application of this method is faced with numerous limitations, including...
4.
Guangmei D, Weishan H, Wenya L, Fasheng W, Jibing C
Clin Transl Oncol
. 2024 Apr;
26(9):2142-2155.
PMID: 38594379
Radiation-induced skin damage (RID) is the most prevalent, significant side effect of radiotherapy (RT). Nearly 95% of patients experience moderate to severe skin reactions after receiving radiation therapy. However, criteria...
5.
Jibing C, Weiping L, Yuwei Y, Bingzheng F, Zhiran X
Regen Ther
. 2024 Jan;
25:101-112.
PMID: 38178928
Based on engineered cell/exosome technology and various skin-related animal models, exosomal microRNA (miRNA)-based therapies derived from natural exosomes have shown good therapeutic effects on nine skin diseases, including full-thickness skin...
6.
Zengzhao W, Xuan L, Xiaohan M, Encun H, Jibing C, Hongjun G
Urol Oncol
. 2023 Nov;
42(1):3-17.
PMID: 37989693
Bladder cancer (BC), a malignancy originating in the epithelial tissue in the inner wall of the bladder, is a common urological cancer type. BC spreads through 3 main pathways: direct...
7.
Weishan H, Donglin Z, Guangmei D, Wenya L, Fasheng W, Jibing C
Clin Transl Oncol
. 2023 Nov;
26(5):1063-1076.
PMID: 37921958
Non-small-cell lung cancer (NSCLC) has an extremely low 5-year survival rate, with the only effective treatment being immunoradiotherapy (iRT). Here, we review the progress of clinical research on iRT for...
8.
Minhua Q, Bingzheng F, Zhiran X, Yingying Z, Yuwei Y, Ting Z, et al.
Curr Stem Cell Res Ther
. 2023 May;
19(5):669-677.
PMID: 37165494
Exosomal-microRNAs (Exo-miRNAs) are key regulators of islet cell function, including insulin expression, processing, and secretion. Exo-miRNAs have a significant impact on the outcomes of islet transplantation as biomarkers for evaluating...
9.
Zhoujun Z, Bingzheng F, Yuwei Y, Yingying Z, Zhiran X, Chunhua H, et al.
Artif Organs
. 2023 Apr;
47(8):1298-1308.
PMID: 37032529
Background: Islet cell transplantation is an emerging therapy in the treatment of diabetes mellitus. Differentiation of islet cells from mesenchymal stem cells (MSCs) is a potential solution to the challenge...
10.
Sataer X, Qifeng Z, Yingying Z, Chunhua H, Bingzhenga F, Zhiran X, et al.
Neurol Res
. 2022 Oct;
45(3):191-199.
PMID: 36184105
Originating from slow irreversible and progressive loss and dysfunction of neurons and synapses in the nervous system, neurodegenerative diseases (NDDs) affect millions of people worldwide. Common NDDs include Parkinson's disease,...